NovaBridge Biosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio46.08
Forward P/E85.14
P/S Ratio249.50-223.95263.2114.07
P/B Ratio0.340.650.825.083.86
Price/Tangible Book0.340.650.915.424.06
Price/FCF50.99
Price/OCF50.05
Enterprise Value Ratios
EV/Revenue210.4313.18
EV/EBITDA120.82
EV/EBIT130.71
EV/FCF47.78
Profitability & Returns
Return on Equity (ROE)-0.22%-0.25%-0.26%-0.46%0.14%
Return on Assets (ROA)-0.11%-0.06%-0.05%-0.22%0.02%
Return on Invested Capital (ROIC)-3.39%0.34%
Return on Capital Employed (ROCE)-0.25%-0.16%-0.11%-0.42%0.03%
Leverage & Solvency Ratios
Debt/Equity0.020.020.030.030.00
Debt/EBITDA0.08
Debt/FCF0.03
Liquidity Ratios
Current Ratio20.905.674.787.669.28
Quick Ratio20.655.394.607.489.12
Efficiency Ratios
Asset Turnover0.000.010.38
Yield & Distribution Ratios
Earnings Yield-0.32%-1.32%-1.07%-0.10%0.02%
FCF Yield-1.54%-0.93%-0.27%-0.04%0.02%
Buyback Yield0.02%-0.01%-0.09%-0.11%-20.30%